ANN ARBOR, Mich., March 07, 2018 -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) (TSX-V:ZOM), a veterinary diagnostic and pharmaceutical company, today announced that it will present at the 30th Annual ROTH Conference on March 13, 2018 in Dana Point, CA.
Chief Executive Officer Gerald Solensky, Jr. will provide an overview of Zomedica’s business during his live presentation and will be available to participate in one-on-one meetings with investors registered to attend the conference.
30th Annual ROTH Conference
Date: Tuesday, March 13, 2018
Time: 2:30 p.m. PDT
Location: The Ritz-Carlton Laguna Nigel, Dana Point, CA
Investors and other interested parties will be able to access a live webcast of the presentation by visiting Zomedica’s website at http://investors.zomedica.com. A replay of the webcast will be accessible on the Zomedica website following the event.
About Zomedica
Based in Ann Arbor, Michigan, Zomedica (NYSE American:ZOM) (TSX-V:ZOM) is a veterinary diagnostic and pharmaceutical and company creating products for companion animals (canine, feline and equine) by focusing on the unmet needs of clinical veterinarians. Zomedica’s product portfolio will include novel diagnostics and innovative therapeutics that emphasize patient health and practice health. With a team that includes clinical veterinary professionals, it is Zomedica’s mission to give veterinarians the opportunity to lower costs, increase productivity, and grow revenue while better serving the animals in their care. For more information, visit www.ZOMEDICA.com.
Follow Zomedica
- Email Alerts: http://investors.zomedica.com
- LinkedIn: https://www.linkedin.com/company/zomedica
- Facebook: https://www.facebook.com/zomedica/
- Twitter: https://twitter.com/zomedica
Reader Advisory
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of the release.
Investor Relations Contacts
Shameze Rampertab, CPA, CA
[email protected]
+1 647.283.3630
PCG Advisory Group
Kirin Smith, COO
[email protected]
+1 646.863.6519
www.pcgadvisory.com
Media Contact
Andrea Eberle
[email protected]
+1 734.369.2555


Heineken H1 Operating Profit Meets Forecast as Beer Volumes Beat Expectations
Siemens Energy Q3 Profit Beats Forecast as AI-Driven Power Demand Fuels Growth
SpaceX Targets Starship Flight 14 With First V3 Starlink Satellite Launch
Nintendo Shares Jump as Switch 2 Sales Boost Earnings
SanDisk Q4 Earnings Beat Estimates as Q1 Revenue Outlook Meets Expectations
Infineon Raises 2026 Revenue Outlook as AI Data Center Demand Fuels Record Quarterly Sales
Moderna Wins FDA Approval for mFLUSIVA mRNA Flu Vaccine for Adults 50+
Novo Nordisk Raises 2025 Outlook Despite Wegovy Pill Miss and CagriSema Setback
Meta AI Model Exploits Security Flaw During Cybersecurity Test, Raising AI Safety Concerns
UOB Q2 Net Profit Rises 10% as Wealth Management Growth Boosts Earnings
Alphabet Stock Slides as Google AI Pioneer Jeff Dean Exits to Launch Discovery Loop
Alibaba Plans Revenue-Sharing Model for Qwen3.8-Max AI Commercial Users
DoorDash Q2 Revenue Jumps 36% as Orders and DashPass Growth Drive Results
UK AI Security Tests Reveal Anthropic and OpenAI Agents Attempted Unauthorized Actions
Cloudflare Stock Jumps 15% as Earnings Beat Estimates, 2026 Outlook Raised
DBS Raises 2025 Outlook After Record Q2 Profit Driven by Wealth Management
OpenAI Restricts Astra AI Over Cyberattack Risks 



